Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors
67%
Oxidoreductases
63%
Highly Active Antiretroviral Therapy
55%
HIV
47%
Mortality
34%
HIV Infections
17%
RNA
13%
Coenzyme A
12%
Inflammation
11%
Liver Failure
10%
Coinfection
9%
Hepatitis
9%
HIV-1
8%
Acquired Immunodeficiency Syndrome
8%
Hemoglobins
7%
Disease Progression
7%
Cause of Death
7%
Cholesterol
7%
Clinical Trials
6%
Demography
6%
Infections
4%
Therapeutics
3%
Neoplasms
3%
Agriculture & Biology
therapeutics
53%
HIV infections
29%
death
22%
inflammation
17%
viral hepatitis
16%
liver failure
15%
RNA
13%
disease progression
12%
Human immunodeficiency virus 1
12%
coenzyme A
12%
at-risk population
11%
clinical trials
10%
mixed infection
10%
demographic statistics
8%
hemoglobin
8%
cholesterol
7%
infection
5%
methodology
2%
Chemical Compounds
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Antiretroviral
84%
Hemoglobin
9%
Cholesterol
8%
Time
3%